Risk factors for tuberculosis after gastrectomy in gastric cancer

Table 2 Clinical and demographic characteristics of 16 tuberculosis patients after gastrectomy

Case	Sex/age	Historyof TB	Previoushealed TBon CXR	Smokinghistory	BMI(kg/m2)	Gastrectomyextent	Cancerstage	From surgery to TB onset (mo)	Site ofTB infection	TB diagnosismethod	TB treatmentoutcome
1	M/83	+	-	±	25.3	Total	IA	62	Lung	Culture	Death1
2	M/59	-	+	+	18.2	Total	IA	34	Lung	Culture	Cure
3	M/42	+	-	+	21.8	Total	IA	52	Lung	Culture	Cure
4	F/40	-	-	-	17.6	Subtotal	IA	13	Lung	Pathology (TBLB)	ND2
5	M/54	-	-	±	21.1	Subtotal	IA	7	Neck LN	Pathology (LN)	ND2
6	M/79	-	+	±	18.3	Subtotal	IA	46	Lung	Culture	Cure
7	M/52	-	-	±	17.2	Subtotal	IIIB	3	Neck LN	Pathology (LN)	Cure
8	M/45	+	+	+	23.6	Total	IB	16	Lung	Culture	Cure
9	F/71	-	-	-	24.9	Subtotal	IIIB	42	Lung	Culture	Cure
10	M/54	+	+	±	19.0	Subtotal	II	4	Lung	Pathology (VATS)	Cure3
11	M/41	-	-	±	23.4	Subtotal	IA	13	Intestine	Pathology (colon)	Cure
12	M/54	-	+	±	23.5	Total	IA	18	Lung, pleura	Culture	Cure
13	M/47	-	-	+	23.0	Total	IB	39	Lung	Clinical	Cure
14	M/62	+	-	+	24.3	Subtotal	IA	10	Lung	Clinical	Cure
15	M/67	-	-	±	20.0	Total	IA	9	Lung	Culture	Cure
16	M/67	+	+	±	23.9	Total	IB	39	Lung	Clinical	Cure

¹Death due to lung cancer progression during TB treatment;

²Patients were referred to other hospitals during TB treatment;

³Lung lesion by TB was resected and TB medication was used for only 2 wk due to side effects, but the patient was considered to be cured clinically. TB: Tuberculosis; BMI: Body mass index; CXR: Chest X-ray; LN: Lymph node; TBLB: Transbronchial lung biopsy; VATS: Video-assisted thoracoscopic surgery ± former smoker.